long term side effects semaglutide 20 Ozempic and Wegovy You Should Know About Unveiling the Complexities of Semaglutide:

Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is a GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management

If a patient discontinues semaglutide for more than two weeks, then it is recommended to re-initiate treatment at the 0.25 mg once-weekly dose and follow the original titration schedule

If potassium abnormalities are detected, management may include dietary modification, adjustment of concomitant medications, or temporary interruption of Ozempic until symptoms resolve and electrolyte balance is restored

Oral semaglutide, FDA-approved for weight loss, offers a range of long-term benefits that extend beyond just shedding pounds

A plan that covered Ozempic in 2025 may have removed it in 2026, or vice versa

It explains how results may vary between individuals, what typical timelines look like, and why gradual, supervised weight loss is often more sustainable than rapid short-term changes